Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

China flag China · Delayed Price · Currency is CNY
25.40
+0.22 (0.87%)
At close: Jan 23, 2026
-11.19%
Market Cap4.91B
Revenue (ttm)842.11M
Net Income (ttm)-479.50M
Shares Out193.20M
EPS (ttm)-2.49
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,998,376
Average Volume2,021,029
Open25.18
Previous Close25.18
Day's Range25.10 - 25.40
52-Week Range21.14 - 36.00
Beta1.14
RSI57.19
Earnings DateApr 29, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn... [Read more]

Sector Healthcare
Founded 2005
Employees 2,276
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688298
Full Company Profile

Financial Performance

In 2024, SHA:688298's revenue was 827.92 million, an increase of 0.95% compared to the previous year's 820.16 million. Losses were -529.02 million, 33.1% more than in 2023.

Financial Statements